Всичко важно за вас на едно място
Следете емисии: блогове, новини, RSS и още. Лесен начин да четете и наваксвате с избраното от вас съдържание.
Вземете FeederRSS емисии за Фармацевтика
Най-следваните от потребителите на Feeder RSS емисии за Фармацевтика, включително Perspective Therapeutics Press Releases, AdvanCell News и Journal of Medicinal Chemistry advanceAccess. Копирайте URL адрес на емисия или ги следвайте безплатно във Feeder.
Свързани теми
RSS емисии за Здраве RSS емисии за Онкология RSS емисии за Клинични изпитвания RSS емисии за Медицински изследвания RSS емисии за Психично здраве RSS емисии за Психология RSS емисии за Обществено здраве
Предложи редакцияClinicalTrials.gov: Migraine | Funded by Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Migraine | Funded by Industry | Last update posted in the last 14 days
Zai Lab Press Releases
Innate Pharma - Press Releases
ScienceDirect Publication: Bioorganic & Medicinal Chemistry
ScienceDirect RSS
Business Wire - News by Company: Arcus Biosciences, Inc.
Business Wire - The global leader in news distribution
Business Wire - News by Company: Samsung Bioepis Co., Ltd.
Business Wire - The global leader in news distribution
ClinicalTrials.gov: Iptacopan | Interventional Studies | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Iptacopan | Interventional Studies | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: CROVALIMAB | Interventional Studies | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: CROVALIMAB | Interventional Studies | Industry | Last update posted in the last 14 days
Press Releases | Alnylam Pharmaceuticals, Inc.
Read our most recent press releases and search through our archive of releases.
ClinicalTrials.gov: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: FAK | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: FAK | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS | Funded by Industry | First posted in the last 14 days
ClinicalTrials.gov: Other terms: CEA | Funded by Industry | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: CEA | Funded by Industry | First posted in the last 14 days
New and updated CTIS clinical trials of the last 7 days
Feed highlighting the new and updated clinical trials published on CTIS of the past 7 days based on the selected search criteria
New and updated CTIS clinical trials of the last 7 days
Feed highlighting the new and updated clinical trials published on CTIS of the past 7 days based on the selected search criteria
ClinicalTrials.gov: brensocatib | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: brensocatib | First posted in the last 14 days
ClinicalTrials.gov: Other terms: brensocatib | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: brensocatib | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: brensocatib | First posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: brensocatib | First posted in the last 14 days
ClinicalTrials.gov: Epidermolysis Bullosa | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Epidermolysis Bullosa | Last update posted in the last 14 days
Qilu Pharmaceutical News
ClinicalTrials.gov: Obesity | Phase: Early Phase 1, 1, 2, 3, 4 | Funded by Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Obesity | Phase: Early Phase 1, 1, 2, 3, 4 | Funded by Industry | Last update posted in the last 14 days